P. Hiemstra (Leiden, Netherlands), A. Somborac Bacura (Zagreb, Croatia), C. Bingle (Sheffield (South Yorkshire), United Kingdom), S. Pouwels (Groningen, Netherlands)
Ykl-40 and phenotyping of severe asthma M. Castro (Lisbon, Portugal), G. Lockett (Southampton, United Kingdom), . Lau (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), E. Scott (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), J. Holloway (Southampton, United Kingdom)
|   |
Expression of CCR3 on sputum macrophages in asthma, COPD and healthy subjects M. Proboszcz (Warsaw, Poland), P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), K. Górska (Warsaw, Poland), P. Misiukiewicz-Stepien (Warsaw, Poland), R. Krenke (Warsaw, Poland)
|  |
Phenotyping neutrophils in COPD through surface proteins M. Hughes (Birmingham, United Kingdom), W. Mciver (Birmingham, United Kingdom), H. Mcgettrick (Birmingham, United Kingdom), E. Sapey (Birmingham, United Kingdom)
|  |
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia T. Akaba (Tokyo, Japan), M. Kondo (Tokyo, Japan), K. Hara (Tokyo, Japan), A. Kurokawa (Tokyo, Japan), K. Takeyama (Tokyo, Japan), E. Tagata (Tokyo, Japan)
|   |
Effects of extracellular Hsp70, lipoteichoic acid and lipopolysaccharide on TLR2 and TLR4 mRNA expression in monocyte-derived macrophages M. Grdic Rajkovic (Zagreb, Croatia), A. Hulina Tomaškovic (Zagreb, Croatia), A. Somborac Bacura (Zagreb, Croatia), I. Hlapcic (Zagreb, Croatia), M. Samardžija (Zagreb, Croatia), M. Bosnar (Zagreb, Croatia), L. Rumora (Zagreb, Croatia)
|   |
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma B. Jouleh (Bergen, Norway), R. Nielsen (Bergen, Norway), P. Bakke (Bergen, Norway), R. Sandvik (Bergen, Norway), T. Kalananthan (Bergen, Norway), J. Ward (Southampton, United Kingdom), S. Wilson (Southampton, United Kingdom), T. Eagan (Bergen, Norway)
|  |
Human airway trypsin-like protease stimulates protease activated receptors and interactions of these receptors M. MIKI (Toyonaka, Japan), S. Yasuoka (Tokushima, Japan), R. Tsutsumi (Tokushima, Japan), Y. Takeuchi (Toyonaka, Japan), K. Miki (Toyonaka, Japan), S. Kitada (Toyonaka, Japan)
|  |
Mitochondrial membrane potential evaluation in children with chronic non-specific lung diseases (CNLD) E. Yakovlev (Khabarovsk, Russian Federation), G. Evseeva (Khabarovsk, Russian Federation), N. Kuderova (Khabarovsk, Russian Federation), S. Pichugina (Khabarovsk, Russian Federation)
|  |
Dividing neutrophils in subsets, reveals a significant role for CD16highCD62Ldim neutrophils in the development of airway hyperreactivity S. Ekstedt (Stockholm, Sweden), J. Säfholm (Stockholm, Sweden), H. Stenberg (Lund, Sweden), E. Tufvesson (Lund, Sweden), Z. Diamant (Lund, Sweden), L. Bjermer (Lund, Sweden), S. Kumlien Georén (Stockholm, Sweden), L. Cardell (Stockholm, Sweden)
|   |
Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils A. Dy (Tucson, United States of America), N. Barker (Tucson, United States of America), P. Langlais (Tucson, United States of America), J. Ledford (Tucson, United States of America)
|  |
Study of the inflammatory phenotype of asthmatic patients with bronchiectasis D. Ma (Barcelona, Spain), M. Cruz (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), D. Clofent (Barcelona, Spain), D. Varona (Barcelona, Spain), X. Muñoz (Barcelona, Spain)
|  |
Sputum autoantibodies are more relevant in autoimmune responses in asthma than are serum autoantibodies J. Li (Guangzhou, China), R. Qin (Guangzhou, China), F. Long (Guangzhou, China), X. Xiao (Guangzhou, China), J. Xiao (Guangzhou, China), M. Feng (Guangzhou, China), Z. Zheng (Guangzhou, China), R. Huang (Guangzhou, China), T. Peng (Guangzhou, China)
|  |
Imbalance in memory B-cells in patients with pulmonary sarcoidosis U. Zinchenko (St. Petersburg, Russian Federation), I. Kudryavtsev (St. Petersburg, Russian Federation), A. Starshinova (St. Petersburg, Russian Federation), N. Basantsova (St. Petersburg, Russian Federation), M. Serebriakova (St. Petersburg, Russian Federation), A. Malkova (St. Petersburg, Russian Federation), E. Toubi (Haifa, Israel), L. Churilov (St. Petersburg, Russian Federation), P. Yablonskiy (St. Petersburg, Russian Federation)
|  |
Biomarkers to identify tissue eosinophils in wheezing children M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), D. Snijders (Padova, Italy), G. Turato (Padova, Italy), C. Rigobello (Padova, Italy), D. Biondini (Padova, Italy), M. Tiné (Padova, Italy), M. Cosio (Montreal , Canada), A. Barbato (Padova, Italy), M. Saetta (Padova, Italy), S. Baraldo (Padova, Italy)
|  |
Analysis of phenotypes in a group of severe asthma S. Louhaichi (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), A. Akkad (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), A. Berraies (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
|  |
Airway eosinophilic inflammation, body weight and symptoms in COPD over 4 years of follow-up J. Gao (Helsinki, Finland), H. Iwamoto (Hiroshima, Japan), T. Toljamo (Rovaniemi, Finland), P. Nieminen (Oulu, Finland), W. Mazur (Helsinki, Finland)
|   |
LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients S. Hardy (Munich, Germany), A. Schneider (Munich, Germany), M. Frankenberger (Munich, Germany), A. Koch (Munich, Germany), K. Milger (Munich, Germany), C. Moulin (Brussels, Belgium), M. Fievez (Brussels, Belgium), C. Pilette (Brussels, Belgium), S. Meiners (Munich, Germany), I. Kammerl (Munich, Germany)
|   |
Pro-inflammatory / anti-inflammatory capacity of lymphocyte cells in COPD J. Rigual Bobillo (Madrid, Spain), M. Calle Rubio (Madrid, Spain), A. López Farré (Madrid, Spain), J. Álvarez-Sala Walther (Madrid, Spain), J. Zamorano León (Madrid, Spain), M. De La Serna Soto (Madrid, Spain), G. Rubio De La Garza (Madrid, Spain), A. Palomar Santamaria (Madrid, Spain), D. Chiluiza Reyes (Madrid, Spain), J. Rodríguez Hermosa (Madrid, Spain)
|   |
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms V. Sileikiene (Vilnius, Lithuania), A. Laurinaviciene (Vilnius, Lithuania), D. Lesciute-Krilaviciene (Vilnius, Lithuania), L. Jurgauskiene (Vilnius, Lithuania), J. Norkuniene (Vilnius, Lithuania), A. Laurinavicius (Vilnius, Lithuania)
|   |